Brent Ashton was named the Chief Executive Officer of the Corporation on January 4, 2024. Mr. Ashton leads all aspects of strategy and execution for the Corporation. Mr. Ashton brought extensive global MedTech leadership experience with him to the Corporation. In his most recent role prior to joining the Corporation, Mr. Ashton was the Vice President and General Manager for Becton Dickinson’s global Specimen Management Business Group. Prior to joining BD, Mr. Ashton spent 13 years in leadership positions with 3M Health Care where he led global businesses in the areas of Wound Care, Vascular Access, and Infection Prevention.
Mr. Ashton has a Bachelor of Arts in Honors Business Administration from the Ivey School of Business at Western University in London, Canada.